Nike's stock sees a 24% dip amid tariff challenges and weak Q4 metrics. Click here to read an analysis of NKE stock now.

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

Microchip Technology's 2024 struggles with high inventory, debt, and economic challenges make it a risky investment. Read why ...

Silver, while volatile and heavily used in industry, serves as a proxy for gold, especially during fear trades. Expert Don ...

RBC cuts its 2025 S&P target by 11% to 5,550, seeing a growth scare rising amid Trump tariffs. Read more here.

The yardstick of fear among investors, the CBOE Volatility Index, surged past 28 on Thursday, well above its 10-year average.

Recession odds are rising. Read more on the long-term market reaction and what investors are doing to prepare for volatile times.

Shares 20+ Year Treasury Bond ETF benefits from tariff impacts and lower growth expectations. Find out why I have a buy ...

Invest smartly with dividend growth stocks! Learn how consistent dividend increases and solid financial health build ...

Sky Harbour Group's long-term growth potential justifies a speculative buy, with a price target of $22.28 once revenue goals ...

Imperial Brands' dividend yield dropped from 11% to 5.5%, making it less attractive amid rising bond yields. Read why IMBBF ...

Spain's industrial production recorded a YoY decline of 1.9% in February, worsening from the 1.2% contraction observed in Jan ...